Alx Oncology Holdings (ALXO) Change in Account Payables (2019 - 2026)

Alx Oncology Holdings has disclosed Change in Account Payables across 8 years of filings, most recently posting -$1.2 million for Q1 2026.

• Change in Account Payables for Q1 2026 came in at -$1.2 million, down 117.63% year-over-year; the trailing twelve-month figure through Mar 2026 was -$233000.0 (up 89.66% YoY), and the FY2025 annual result was $421000.0, up 110.46% from the prior year.
• Change in Account Payables came in at -$1.2 million for Q1 2026 at Alx Oncology Holdings, up from -$1.7 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $8.9 million in Q3 2023 to a low of -$5.7 million in Q2 2023.
• The 5-year median for Change in Account Payables is -$194000.0 (2024), against an average of $8882.4.
• Across the five-year window, Change in Account Payables tumbled 282.72% in 2023 and surged 966.49% in 2025, its largest moves.
• Alx Oncology Holdings' Change in Account Payables stood at $2.5 million in 2022, then sank by 282.72% to -$4.5 million in 2023, then advanced by 24.46% to -$3.4 million in 2024, then soared by 50.72% to -$1.7 million in 2025, then climbed by 27.5% to -$1.2 million in 2026.
• The last three Change in Account Payables figures came in at -$1.2 million (Q1 2026), -$1.7 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.